1. Market Research
  2. > Pathology
60 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Breast Implants Market with Focus on Breast Augmentation & Breast Reconstruction: Size, Trends and Forecasts (2019-2023)

  • $ 1200
  • August 2019
  • 116 pages

Also, smooth breast implants have a lower risk of suffering from breast implant-associated anaplastic large-cell lymphoma than textured breast implants.

  • Lymphoma
  • Medical Device
  • Prosthesis
  • World
  • Allergan plc

Breast Implants Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product ; Application, Surface Type, and Geography

  • $ 4550
  • April 2020
  • 155 pages

The cancer is linked to breast implants; the FDA calls the cancer breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL).

  • Lymphoma
  • Medical Device
  • Prosthesis
  • Forecast
  • Allergan plc

Tissue Engineering Market to 2027 - Global Analysis and Forecasts by Tissue Type ; Application, and Geography

  • $ 4550
  • March 2020
  • 163 pages

Gene therapy and cell therapy are transforming the cancer treatment landscape; for example, Novartis Kymriah is used in the treatment of diffuse large B-cell lymphoma.

  • Lymphoma
  • Medical Biotechnology
  • Tissue Engineering
  • Forecast
  • Allergan plc

Breast Implants Market to 2027- Global Analysis and Forecasts by Product, Application, Surface Type, and Geography

  • $ 4550
  • February 2019
  • 145 pages

The cancer is linked to breast implants; the FDA calls the cancer breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL).

  • Lymphoma
  • Medical Device
  • Prosthesis
  • Forecast
  • Allergan plc

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico

  • $ 1995
  • August 2019
  • 120 pages

Product Recall: GSK discontinued the global development of GSK-## in Phase I stage of development for relapsed or refractory small-cell lung cancer; and GSK-## in Phase I stage of development for follicular lymphoma, diffuse large B-cell lymphoma, solid tumor and refracto

  • Lymphoma
  • Medical Equipment
  • Pharmaceutical
  • Mexico
  • Allergan plc

Axillary Hyperhidrosis - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 53 pages

The Merger would create a pharmaceutical company focused on developing novel and differentiated prescription therapies addressing unmet patient needs in hyperhidrosis, cutaneous Tcell lymphoma, psoriasis, and other debilitating dermatologic disorders.

  • Dermatological Condition
  • Therapy
  • United States
  • Allergan plc
  • Bodor Laboratories, Inc.

Dermatology Drugs Market Global Briefing 2018

  • $ 1000
  • January 2018
  • 29 pages

The dermatology drugs market includes medications that are used for the treatment of skin conditions such as dermatitis (including eczema), rosacea, hyperhidrosis, androgenic alopecia, onychomycosis, hai ...

  • Dermatological Treatment
  • Lymphoma
  • World
  • Allergan plc
  • Galderma S.A.

The Global Dermatology Market to 2028

  • $ 2849
  • June 2018
  • 180 pages

The global dermatological (prescription) drugs market was valued at $38.4bn in 2017, GMR Data forecast that this will rise to $44.1bn across 2018. The third in a series of biennial Dermatology reports ...

  • Autoimmune Disease
  • Dermatological Condition
  • Dermatology
  • Lymphoma
  • Allergan plc

Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market

  • $ 4995
  • February 2018
  • 91 pages

Further correlations of an increased risk of malignancies were also identified for non-melanoma skin cancer, as well as for lymphoma and leukemia.

  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Market Size
  • Allergan plc

Global Glaucoma Therapeutics Market 2017-2021

  • $ 2500
  • October 2017
  • 97 pages

TECHNAVIO.

  • Eye Disease
  • Ophthalmology
  • Therapy
  • Allergan plc
  • Merck & Co., Inc.

Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape

  • $ 2995
  • January 2019
  • 99 pages

In October 2017, Gilead acquired Kite Pharma for Yescarta, the first CAR-T product for B-cell lymphoma.

  • Gene Therapy
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • Allergan plc

Analyzing the Global Market for Active Pharmaceutical Ingredients 2018

  • $ 1200
  • October 2018
  • 390 pages

Under Oncology, the company is developing CTL## for pediatric acute lymphoblastic leukemia and large B-cell lymphoma; LCI## for Cushing' s disease; ABL## for Chronic myeloid leukemia; INC## for Non-small cell lung cancer; BYL## for advanced breast cancer; Jakavi for Graftversus-hos

  • Biotechnology
  • Lymphoma
  • Pharmaceutical
  • Market Size
  • Allergan plc

Pharmaceutical Drugs Global Market Report 2018

  • $ 8000
  • March 2018
  • 455 pages

Its importance results from the large population of cancer patients suffering from various types of blood cancers such as leukemia, lymphoma, and myeloma.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Market Size
  • Allergan plc

World Prescription Dermatological Drugs Market, 10th Edition

  • $ 4200
  • June 2017
  • 414 pages

ITS PRINCIPAL INDICATIONS ARE FOR CENTRAL NERVOUS SYSTEM MALIGNANCIES, LYMPHOMAS, MELANOMA, AND GASTROINTESTINAL TUMORS.

  • Antifungal
  • Dermatological Condition
  • Lymphoma
  • Therapy
  • Allergan plc

Market for Active Pharmaceutical Ingredients in Japan - Forecast and Analysis 2018

  • $ 850
  • November 2018
  • 145 pages

Under Oncology, the company is developing CTL## for pediatric acute lymphoblastic leukemia and large B-cell lymphoma; LCI## for Cushing' s disease; ABL## for Chronic myeloid leukemia; INC## for Non-small cell lung cancer; BYL## for advanced breast cancer; Jakavi for Graftversus-hos

  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Allergan plc
  • Novartis AG

Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis

  • $ 4995
  • July 2017
  • 136 pages

In addition, the reported lymphoma cases were no greater than the expected rate in the general population (Munzenberger and Montejo, 2007).

  • Dermatological Condition
  • Dermatology
  • Lymphoma
  • Therapy
  • Allergan plc

Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers

  • $ 4995
  • September 2017
  • 155 pages

THE FOURTH CHAPTER ANALYZES THE RESPIRATORY DISORDERS PIPELINE, DETAILING, AMONG OTHER PARAMETERS, DRUG DISTRIBUTION BY STAGE OF DEVELOPMENT, MOLECULE TYPE AND MOLECULAR TARGET, PLUS AN ANALYSIS OF THE KEY INDICATIONS IN THE PIPELINE: LEUKEMIA, LYMPHOMA AND MYELOMA.

  • Lymphoma
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Allergan plc

Frontier Pharma: Dermatology - Intracellular Signal Transducers and Cytokine Signaling Molecules Dominate Pipeline and First-in-Class Innovation

  • $ 6995
  • June 2017
  • 1 pages

Aggressive lymphomas.

  • Dermatology
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Allergan plc

Analyzing Generics Market in Canada 2017

  • $ 850
  • August 2017
  • 90 pages

In February 2015, the company discontinued SAR-##, which was in Phase I trial for the treatment of advanced solid tumors or lymphomas, metastatic braf-mutated melanoma and PTEN deficient tumors.

  • Lymphoma
  • Pharmaceutical
  • Allergan plc
  • Apotex Inc.
  • Mylan Inc.

Pharmaceutical Industry in the United States 2018

  • $ 850
  • September 2018
  • 150 pages

As of February 2017, Merck has ## programs in Phase II stage for asthma, ovarian cancer, advanced solid tumors, nasopharyngeal cancer, primary mediastinal large Bcell lymphoma, prostate cancer, cough, including cough with idiopathic pulmonary fibrosis, diabetes mellitus, hepatitis C and pne

  • Lymphoma
  • Pharmaceutical
  • Allergan plc
  • Merck & Co., Inc.
  • Mylan Inc.

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on